Iridex Welcomes Juan Carlos Torres as International Sales Area Manager for Latin America and Canada > IRIDEX



Mountain View, CA — April 5, 2022 — Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announces the appointment of Juan Carlos Torres to the Iridex team as the International Sales Area Manager for Latin America and Canada (LACA).

Juan Carlos Torres brings over 22 years of expertise in developing and managing sales of ophthalmic products in the LACA region. “His experience in selling consumable surgical laser products, as well as capital diagnostic and treatment equipment, will help Iridex reconfirm its distinction as a trusted supplier for innovative and versatile laser systems, delivery devices, and consumables to physicians and distributors in Latin America and Canada,” said Bassem Bouhabib, Vice President, International Sales, Iridex.

Specialized in opening and managing international markets, Juan Carlos is a strong leader in directing and motivating sales team members and distributor networks to exceed targets. “I am proud to join Iridex. It is truly a pleasure and privilege to have this unique opportunity to join such an outstanding team and continue developing and growing the glaucoma and retina laser markets with my colleagues in the industry,” said Juan Carlos.

“I am very pleased to welcome Juan Carlos to our sales team,” said Dave Bruce, CEO of Iridex. “Juan Carlos’s extensive management and sales experience in the ophthalmic industry and LACA market makes him the perfect candidate for our international team.”

About Iridex

Iridex is a worldwide leader in developing innovative and versatile laser-based medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and proven therapy for targeted sight-threatening eye conditions. Iridex’s products treat glaucoma, diabetic macular edema, and other retinal diseases. Iridex products are sold in the United States and Germany through a direct sales force and in more than 100 countries through a network of independent distributors. For more information, visit

Iridex Media Contact

Jamie Hall

Posted in: News
Actions: E-mail | Permalink |